Sponsor

University of Messina

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name University of Messina appears in 18 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials18
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

18 shown
Liver and Coagulation Disorders in Cardiac Transthyretin AmyloidosisNCT07766135 · lead sponsor · 2026-01-30
RECRUITING
Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic SubjectsNCT06787781 · lead sponsor · 2021-06-01
COMPLETED
Myoinositol Supplementation, Insulin Resistance and Fetal Sonographic Parameters in Gestational Diabetes Diet TreatedNCT03763669 · lead sponsor · 2018-11-14
COMPLETED
Role of NLRP3 in Periodontitis and DiabetesNCT04450810 · lead sponsor · 2014-06-01
COMPLETED
Myo-inositol Administration in Gestational DiabetesNCT00734448 · lead sponsor · 2013-11-01
UNKNOWN
Myo-inositol in Obese Pregnant WomenNCT01047982 · lead sponsor · 2010-03-01
COMPLETED
Effects of Genistein in Postmenopausal Women With Metabolic SyndromeNCT01664650 · lead sponsor · 2008-09-01
COMPLETED
Effect of Genistein in Women With Metabolic SyndromeNCT00541710 · lead sponsor · 2007-10-01
COMPLETED
Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic UlcersNCT00638872 · lead sponsor · 2007-10-01
COMPLETED
Insulin Resistance and Hypertensive Disorders in PregnancyNCT00412230 · lead sponsor · 2006-10-01
COMPLETED
Real-world Study on the Effectiveness and Safety of Control-IQ Technology in Teenagers With Type 1 Diabetes Engaging in Regular Physical ActivityNCT06876207 · collaborator · 2025-06-01
RECRUITING
Real-World Evaluation of TouchCare Nano in Pediatric Type 1 DiabetesNCT07425912 · collaborator · 2025-09-05
COMPLETED
A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and RectumNCT06950996 · collaborator · 2024-09-01
COMPLETED
CCT for Comprehensive Risk Stratification Following STEMINCT06020209 · collaborator · 2023-11-08
UNKNOWN
The Impact of Daily Carbohydrate Intake on Glycemic Control in Children and Adolescents With Type 1 Diabetes Using an Advanced Hybrid Closed-loop SystemNCT05866900 · collaborator · 2023-05-15
COMPLETED
Effect of Transcranial Direct Current Stimulation (tDCS) and Probiotic Supplementation in Overweight AdultsNCT06035718 · collaborator · 2023-03-01
UNKNOWN
Endometrial Changes in Breast Cancer Women.NCT05717634 · collaborator · 2023-01-26
UNKNOWN
Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection FractionNCT04397302 · collaborator · 2019-01-13
COMPLETED

Drugs studied in this sponsor's trials

1 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Messina as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Sponsor roles

lead sponsor10
collaborator8
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.